elebsiran
elebsiran: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Vir Biotechnology, Inc. (VIR) | Phase 3 |
Clinical Trials (1)
A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide (ECLIPSE 2)
Frequently asked questions
Who is developing elebsiran?
elebsiran is being developed by Vir Biotechnology, Inc..
How many clinical trials involve elebsiran?
BioSniper tracks 1 clinical trial involving elebsiran.
Get deeper analysis on elebsiran
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis